As the outbreak of COVID-19 – a disease caused by a novel strain of coronavirus – evolves in the United States and around the globe, the biopharmaceutical industry is working around the clock to find solutions. PhRMA Members are working tirelessly to develop ways to diagnose, prevent and treat those with coronavirus. These companies are also donating medical supplies, personal protective equipment, existing treatments and medicines, and are providing monetary support to front line response teams.